Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Bicara Therapeutics Inc. (BCAX) had Non-Operating Income/Expense of $4.39M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-36.33M |
|
-- |
|
-- |
|
$40.68M |
|
$-40.68M |
|
|
Non-Operating Income/Expense |
$4.39M |
$-36.29M |
|
$-36.29M |
|
$-36.33M |
|
$-36.33M |
|
$-36.33M |
|
$-36.33M |
|
$-40.68M |
|
$-40.62M |
|
54.56M |
|
54.56M |
|
$-0.67 |
|
$-0.67 |
|
| Balance Sheet Financials | |
$297.37M |
|
$0.14M |
|
$127.32M |
|
$424.69M |
|
$21.03M |
|
-- |
|
$0.88M |
|
$21.91M |
|
$402.78M |
|
$402.78M |
|
$402.78M |
|
54.61M |
|
| Cash Flow Statement Financials | |
$-82.95M |
|
$-236.12M |
|
$1.03M |
|
$489.71M |
|
$171.67M |
|
$-318.04M |
|
$10.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-82.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.02% |
|
-9.02% |
|
-8.55% |
|
-9.02% |
|
$7.38 |
|
$-1.52 |
|
$-1.52 |
|